Alpha Core Capital LLC Connect Biopharma Holdings LTD Transaction History
Alpha Core Capital LLC
- $2.55 Billion
- Q2 2025
A detailed history of Alpha Core Capital LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Alpha Core Capital LLC holds 80,000 shares of CNTB stock, worth $181,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,000Holding current value
$181,600% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTB
# of Institutions
18Shares Held
2.81MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN1.82MShares$4.13 Million1.35% of portfolio
-
Ubs Oconnor LLC Chicago, IL269KShares$610,5070.01% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$365,1680.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny115KShares$260,5960.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$235,8320.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $125M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...